UPDATE
1-Zafgen to
scrap lead obesity drug, cut jobs
July 19 (Reuters) - Zafgen Inc said it wassuspending the development of its
lead obesity drug, beloranib,more than six months after the U.S. Food and Drug Administrationasked the company to halt...
